Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers
Centers & Departments Core Facilities Post Doctoral Fellowships Research Services Clinical Research (CTSA) Technology Development Research Administration
| Home > Research > Centers & Departments > Center for Human Nutrition >
Research of Scott M. Grundy, MD, PhD
 Home 
 About the Center 
 Facilities 
 Faculty & Staff 
 Research 
 Dr. Scott Grundy - Director 
 Dr. Nicola Abate 
 Dr. Anil Agarwal 
 Dr. Jo Ann Carson 
 Dr. Manisha Chandalia 
 Dr. Jonathan Cohen 
 Dr. Abhimanyu Garg 
 Dr. Elizabeth Parks 
 Dr. Meena Shah 
 Dr. Vinaya Simha 
 Dr. Gloria Vega 
 Center Timeline 
 Center Features 
 Friends of the Center 
 Nutrition Programs 
 Research Conferences 
 CHN Newsletters 
  
  
 

 

Scott GrundyScott M. Grundy, M.D., Ph.D. is the director of the Center for Human Nutrition and Chairman of the Department of Clinical Nutrition at the University of Texas Southwestern Medical Center at Dallas and chief of the metabolic unit, Veterans Affairs Medical Center, in Dallas, Texas. He has also earned the title of Distinguished Professor of Internal Medicine at the University of Texas Southwestern Medical School in Dallas. Previously he had been on the faculty at the University of California, San Diego, the National Institutes of Health Phoenix Clinical Research Unit, the Rockefeller University, New York City, and Baylor College of Medicine, Houston, Texas. Dr. Grundy received his M.D. degree from Baylor College of Medicine and his Ph.D. from the Rockefeller University.

Dr. Grundy has been a member of, or chaired, a number of American Heart Association committees, including the Arteriosclerosis Council, Nutrition Committee, Task Force on Risk Reduction, and Task Force on Cholesterol. He has chaired the Adult Treatment Panel of the National Cholesterol Education Program (NCEP) and is a member of the American Society for Clinical Investigation, the American Association of Physicians, and the National Academies of Sciences Institute of Medicine.

Dr. Grundy received The Award of Merit from The American Heart Association in 1983. He gave the Lydia J. Roberts Memorial Lecture in Chicago in 1988 and the George Lyman Duff Lecture at the 1990 AHA meeting in Dallas. In 1990, he was awarded an honorary degree in medicine from the University of Helsinki, Finland. In 1994, he received the Roger J. Williams Award in preventive nutrition. He was made a member of the Institute of Medicine in 1996 and in 1997 and 1998 he received the Bristol Myers Squibb Award for Distinguished Achievement in Nutrition Research and the American Society for Clinical Nutrition's E.V. McCollum award, respectively. In 2000, Dr. Grundy received the American Heart Association Discovery Award.  In 2002, he gave the 75th Anniversary Lecture of the Council on Nutrition, Physical Activity and Metabolism of the American Heart Association, and in 2003, the  3rd Annual Stare-Hegsted Lecture. Harvard School of Public Health. and the American Heart Association Robert I. Levy Memorial Lecture.  In 2005, Dr. Grundy was named a Distinguished Scientist of the American Heart Association. 

Dr. Grundy's major research area is in cholesterol and lipoprotein metabolism. He has published over 300 original papers, and numerous solicited articles and chapters. Notable research achievements include the development of methods for measuring cholesterol balance and biliary lipid secretion in humans, identifying the metabolic causes of cholesterol gallstones, defining effects of saturated and unsaturated fats, especially monounsaturated fatty acids, on cholesterol and lipoprotein metabolism, uncovering genetic defects underlying hypercholesterolemia and other forms of dyslipidemia, identifying metabolic defects in hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, and defining mechanisms of action of several lipid-lowering drugs, notably fibrates and HMG CoA reductase inhibitors (statins).